GlaxoSmithKline plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other
pharmaceutical manufacturers in Europe:
sales of 36.20 billion Euro [US$44.48 billion]
(49.16 billion Swiss Francs [US$52.35 billion]
of which 66%
was Innovative Medicines), and
Roche Holding Aktiengesellschaft
based in Switzerland
(53.30 billion Swiss Francs [US$56.76 billion]
of which 77%
During the year ended December of 2017, sales at
GlaxoSmithKline plc were £30.19 billion (US$42.04 billion).
increase of 8.2%
versus 2016, when the company's sales were £27.89 billion.
This was the third consecutive year of growth at GlaxoSmithKline plc.